英为财情Investing2020-08-31 16:59
【盘前异动:生物制药公司Aimmune 大涨近170%,雀巢拟每股34.50美元价格收购网页链接】周一美股盘前,美国生物制造公司$Aimmune治疗(AIMT)$ 大涨近170%,报约33.80美元。查看股价:网页链接查看全文
美港电讯APP2020-08-31 16:03
【行情】临床阶段生物制药公司Aimmune Therapeutics 盘前 大涨超160%,此前消息称雀巢将以每股34.5美元现金的价格对其进行收购。 $Aimmune治疗(AIMT)$ $雀巢(NSRGY)$ (来自美港电讯APP)查看全文
$Aimmune治疗(AIMT)$ 8-K Current report, items 1.02, 2.01, 2.04, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-20-272122 Act: 34 Size: 258 KB 网页链接
$Aimmune治疗(AIMT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-028359 Size: 9 KB 网页链接
$Aimmune治疗(AIMT)$ 内部交易: 2020-10-13,10% Owner,Societe des Produits Nestle S. ,买入,54117287普通股, $34.50
$Aimmune治疗(AIMT)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-20-268644 Act: 33 Size: 20 KB 网页链接
$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268646 Act: 33 Size: 25 KB 网页链接
$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268648 Act: 33 Size: 25 KB 网页链接
$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268649 Act: 33 Size: 25 KB 网页链接
$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268654 Act: 33 Size: 25 KB 网页链接
$Aimmune治疗(AIMT)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-20-268640 Act: 33 Size: 20 KB 网页链接
$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268641 Act: 33 Size: 25 KB 网页链接